Cargando…
Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland
Universal rotavirus (RV) vaccination is expected to reduce hospitalizations for acute gastroenteritis (GE) of children by eliminating most of severe RVGE, but it does not have any effect on norovirus (NV), the second most common causative agent of GE in children. After the introduction of the RV vac...
Autores principales: | Hemming, Maria, Räsänen, Sirpa, Huhti, Leena, Paloniemi, Minna, Salminen, Marjo, Vesikari, Timo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086648/ https://www.ncbi.nlm.nih.gov/pubmed/23361964 http://dx.doi.org/10.1007/s00431-013-1945-3 |
Ejemplares similares
-
Noroviruses in children seen in a hospital for acute gastroenteritis in Finland
por: Räsänen, Sirpa, et al.
Publicado: (2011) -
Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®
por: Hartwig, Susanne, et al.
Publicado: (2014) -
Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study
por: Vesikari, Timo, et al.
Publicado: (2010) -
G2P[4]-RotaTeq Reassortant Rotavirus in Vaccinated Child, United States
por: Roy, Sunando, et al.
Publicado: (2015) -
A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines
por: van Hoek, Albert Jan, et al.
Publicado: (2012)